New pill aims to tackle Huntington's at its source
NCT ID NCT06873334
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tests an oral drug called SKY-0515 in 120 adults with Huntington's disease. The goal is to see if it can lower a harmful protein linked to the disease and improve symptoms. Participants take the drug or a placebo for a set period, and researchers monitor changes in protein levels, brain scans, and movement scores.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Auckland City Hospital
Auckland, 1023, New Zealand
-
Calvary Health Care Bethlehem
Caulfield South, Victoria, 3162, Australia
-
Christchurch Neurology Trials Limited
Christchurch, 8011, New Zealand
-
Flinders Medical Centre
Adelaide, South Australia, 5042, Australia
-
Huntington's Disease Association
Auckland, 0604, New Zealand
-
John Hunter Hospital
New Lambton Heights, New South Wales, 2305, Australia
-
Launceston General Hospital
Launceston, Tasmania, 7250, Australia
-
The Perron Institute for Neurology and Translational Science (Perron Institute)
Nedlands, Western Australia, 6009, Australia
-
The Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
-
The University of Queensland
Herston, Queensland, 4006, Australia
-
Wellington Hospital
Wellington, 6021, New Zealand
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.